E-mail a Wiley Online Library Link

Shreyaskumar Patel, Mary Louise Keohan, M. Wasif Saif, Daniel Rushing, Luis Baez, Kevie Feit, Robert DeJager and Sibyl Anderson Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy Cancer 107

Version of Record online: 15 NOV 2006 | DOI: 10.1002/cncr.22334

TZT-1027, a novel antimitotic agent, was tested in patients with soft-tissue sarcomas. In all, 21% of patients experienced stable disease but no objective responses were noted. The drug was safe and well tolerated.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field